Recombinant adenovirus type 5 vectors that target DC-SIGN, ChemR23 and αvβ3 integrin efficiently transduce human dendritic cells and enhance presentation of vectored antigens

Vaccine

Volumn 24, Issue 5, 2006, Pages 671-682

  Maguire, Casey A ^a   Sapinoro, Ramil ^a   Girgis, Natasha ^a,c   Rodriguez Colon, Sol M ^a   Ramirez, Servio H ^a   Williams, Jennifer ^a   Dewhurst, Stephen ^a,b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adenovirus; Dendritic cell; Targeting

Indexed keywords

ADENOVIRUS VECTOR; CD209 ANTIGEN; DENDRITIC CELL VACCINE; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR CHEMR 23; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ANTIGEN PRESENTATION; ARTICLE; BINDING AFFINITY; CD8+ T LYMPHOCYTE; CELL SURFACE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EMBRYO; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; LIGAND BINDING; MEMORY T LYMPHOCYTE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; VIRUS RECOMBINANT; VIRUS STRAIN;

ADENOVIRIDAE; ANTIGEN PRESENTATION; ANTIGENS; ANTIGENS, CD8; BIOTIN; CELL ADHESION MOLECULES; CELLS, CULTURED; DENDRITIC CELLS; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNIZATION; INTEGRIN ALPHAVBETA3; LECTINS, C-TYPE; LIGANDS; PHENOTYPE; RECEPTORS, CELL SURFACE; RECEPTORS, CHEMOKINE; SYNAPTOTAGMIN I; TRANSDUCTION, GENETIC;

EID: 29544435485     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.08.038     Document Type: Article

References (40)

1. J. Banchereau, F. Briere, C. Caux, J. Davoust, S. Lebecque, and Y.J. Liu Immunobiology of dendritic cells Annu Rev Immunol 18 2000 767 811
2. C. Foged, A. Sundblad, and L. Hovgaard Targeting vaccines to dendritic cells Pharm Res 19 3 2002 229 238
3. J.W. Shiver, and E.A. Emini Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors Annu Rev Med 55 2004 355 372
4. L. Jenne, G. Schuler, and A. Steinkasserer Viral vectors for dendritic cell-based immunotherapy Trends Immunol 22 2 2001 102 107
5. K. Jooss, Y. Yang, K.J. Fisher, and J.M. Wilson Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers J Virol 72 5 1998 4212 4223
6. G.P. Bowen, S.L. Borgland, M. Lam, T.A. Libermann, N.C. Wong, and D.A. Muruve Adenovirus vector-induced inflammation: capsid-dependent induction of the C-C chemokine RANTES requires NF-kappa B Hum Gene Ther 13 3 2002 367 379
7. J.N. Higginbotham, P. Seth, R.M. Blaese, and W.J. Ramsey The release of inflammatory cytokines from human peripheral blood mononuclear cells in vitro following exposure to adenovirus variants and capsid Hum Gene Ther 13 1 2002 129 141
8. R. Offringa, K. Kwappenberg, M. Rabelink, D. Rea, and R. Hoeben Adenoviral transduction of dendritic cells Methods Mol Med 109 2005 83 96
9. D. Rea, F.H. Schagen, R.C. Hoeben, M. Mehtali, M.J. Havenga, and R.E. Toes Adenoviruses activate human dendritic cells without polarization toward a T-helper type 1-inducing subset J Virol 73 12 1999 10245 10253
10. N. Okada, Y. Tsukada, S. Nakagawa, H. Mizuguchi, K. Mori, and T. Saito Efficient gene delivery into dendritic cells by fiber-mutant adenovirus vectors Biochem Biophys Res Commun 282 1 2001 173 179
11. B.W. Tillman, T.D. de Gruijl, S.A. Luykx-de Bakker, R.J. Scheper, H.M. Pinedo, and T.J. Curiel Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vector J Immunol 162 11 1999 6378 6383
12. A.V. Pereboev, J.M. Nagle, M.A. Shakhmatov, P.L. Triozzi, Q.L. Matthews, and Y. Kawakami Enhanced gene transfer to mouse dendritic cells using adenoviral vectors coated with a novel adapter molecule Mol Ther 9 5 2004 712 720
13. J.G. Brandao, R.J. Scheper, S.M. Lougheed, D.T. Curiel, B.W. Tillman, and W.R. Gerritsen CD40-targeted adenoviral gene transfer to dendritic cells through the use of a novel bispecific single-chain Fv antibody enhances cytotoxic T cell activation Vaccine 21 19-20 2003 2268 2272
14. A.V. Pereboev, C.K. Asiedu, Y. Kawakami, S.S. Dong, J.L. Blackwell, and E.A. Kashentseva Coxsackievirus-adenovirus receptor genetically fused to anti-human CD40 scFv enhances adenoviral transduction of dendritic cells Gene Ther 9 17 2002 1189 1193
15. D.A. Heideman, V.W. van Beusechem, G.J. Offerhaus, T.J. Wickham, P.W. Roelvink, and M.E. Craanen Selective gene transfer into primary human gastric tumors using epithelial cell adhesion molecule-targeted adenoviral vectors with ablated native tropism Hum Gene Ther 13 14 2002 1677 1685
16. P. Henning, M.K. Magnusson, E. Gunneriusson, S.S. Hong, P. Boulanger, and P.A. Nygren Genetic modification of adenovirus 5 tropism by a novel class of ligands based on a three-helix bundle scaffold derived from staphylococcal protein A Hum Gene Ther 13 12 2002 1427 1439
17. B.G. Barnett, C.J. Crews, and J.T. Douglas Targeted adenoviral vectors Biochim Biophys Acta 1575 1-3 2002 1 14
18. B.W. Tillman, T.L. Hayes, T.D. DeGruijl, J.T. Douglas, and D.T. Curiel Adenoviral vectors targeted to CD40 enhance the efficacy of dendritic cell-based vaccination against human papillomavirus 16-induced tumor cells in a murine model Cancer Res 60 19 2000 5456 5463
19. T.D. de Gruijl, S.A. Luykx-de Bakker, B.W. Tillman, A.J. van den Eertwegh, J. Buter, and S.M. Lougheed Prolonged maturation and enhanced transduction of dendritic cells migrated from human skin explants after in situ delivery of CD40-targeted adenoviral vectors J Immunol 169 9 2002 5322 5331
20. N. Okada, T. Saito, Y. Masunaga, Y. Tsukada, S. Nakagawa, and H. Mizuguchi Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells Cancer Res 61 21 2001 7913 7919
21. N. Okada, Y. Masunaga, Y. Okada, H. Mizuguchi, S. Iiyama, and N. Mori Dendritic cells transduced with gp100 gene by RGD fiber-mutant adenovirus vectors are highly efficacious in generating anti-B16BL6 melanoma immunity in mice Gene Ther 10 22 2003 1891 1902
22. J.L. Richards, J.R. Abend, M.L. Miller, S. Chakraborty-Sett, S. Dewhurst, and L.E. Whetter A peptide containing a novel FPGN CD40-binding sequence enhances adenoviral infection of murine and human dendritic cells Eur J Biochem 270 10 2003 2287 2294
23. S. Worgall, A. Busch, M. Rivara, D. Bonnyay, P.L. Leopold, and R. Merritt Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responses J Virol 78 5 2004 2572 2580
24. M.B. Parrott, K.E. Adams, G.T. Mercier, H. Mok, S.K. Campos, and M.A. Barry Metabolically biotinylated adenovirus for cell targeting, ligand screening, and vector purification Mol Ther 8 4 2003 688 700
25. E.J. Soilleux, L.S. Morris, G. Leslie, J. Chehimi, Q. Luo, and E. Levroney Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro J Leukoc Biol 71 3 2002 445 457
26. J. Richards, M. Miller, J. Abend, A. Koide, S. Koide, and S. Dewhurst Engineered fibronectin type III domain with a RGDWXE sequence binds with enhanced affinity and specificity to human alphavbeta3 integrin J Mol Biol 326 5 2003 1475 1488
27. N. Romani, D. Reider, M. Heuer, S. Ebner, E. Kampgen, and B. Eibl Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability J Immunol Methods 196 2 1996 137 151
28. A. Heim, C. Ebnet, G. Harste, and P. Pring-Akerblom Rapid and quantitative detection of human adenovirus DNA by real-time PCR J Med Virol 70 2 2003 228 239
29. W. Vermi, E. Riboldi, V. Wittamer, F. Gentili, W. Luini, and S. Marrelli Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin J Exp Med 201 4 2005 509 515
30. J. Valladeau, O. Ravel, C. Dezutter-Dambuyant, K. Moore, M. Kleijmeer, and Y. Liu Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules Immunity 12 1 2000 71 81
31. K. Mahnke, M. Guo, S. Lee, H. Sepulveda, S.L. Swain, and M. Nussenzweig The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments J Cell Biol 151 3 2000 673 684
32. M. Samson, A.L. Edinger, P. Stordeur, J. Rucker, V. Verhasselt, and M. Sharron ChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strains Eur J Immunol 28 5 1998 1689 1700
33. D.S. Kwon, G. Gregorio, N. Bitton, W.A. Hendrickson, and D.R. Littman DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection Immunity 16 1 2002 135 144
34. V. Wittamer, J.D. Franssen, M. Vulcano, J.F. Mirjolet, E. Le Poul, and I. Migeotte Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids J Exp Med 198 7 2003 977 985
35. V. Wittamer, F. Gregoire, P. Robberecht, G. Vassart, D. Communi, and M. Parmentier The C-terminal nonapeptide of mature chemerin activates the chemerin receptor with low nanomolar potency J Biol Chem 279 11 2004 9956 9962
36. M.R. Wills, A.J. Carmichael, K. Mynard, X. Jin, M.P. Weekes, and B. Plachter The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL J Virol 70 11 1996 7569 7579
37. N. Korokhov, T.D. de Gruijl, W.A. Aldrich, P.L. Triozzi, P.T. Banerjee, and S.D. Gillies High efficiency transduction of dendritic cells by adenoviral vectors targeted To DC-SIGN Cancer Biol Ther 4 3 2005
38. T.B. Geijtenbeek, S.J. Van Vliet, E.A. Koppel, M. Sanchez-Hernandez, C.M. Vandenbroucke-Grauls, and B. Appelmelk Mycobacteria target DC-SIGN to suppress dendritic cell function J Exp Med 197 1 2003 7 17
39. P. Henning, K.M. Andersson, K. Frykholm, A. Ali, M.K. Magnusson, and P.A. Nygren Tumor cell targeted gene delivery by adenovirus 5 vectors carrying knobless fibers with antibody-binding domains Gene Ther 12 3 2005 211 224
40. A. Koide, C.W. Bailey, X. Huang, and S. Koide The fibronectin type III domain as a scaffold for novel binding proteins J Mol Biol 284 4 1998 1141 1151